• support@madhedgefundtrader.com
  • Member Login
Mad Hedge Fund Trader
  • Home
  • About
  • Store
  • Luncheons
  • Testimonials
  • Contact Us
  • Click to open the search input field Click to open the search input field Search
  • Menu Menu
april@madhedgefundtrader.com

About april@madhedgefundtrader.com

This author has not written his bio yet.
But we are proud to say that april@madhedgefundtrader.com contributed 2301 entries already.

Entries by april@madhedgefundtrader.com

Tech Letter

Are 8% Rates Good For Tech?

Although much of the mass media ignores some of these dire reports issued by some prominent finance guys, I have taken notice. I’m not here to scare you. Everything will work out fine. It was only just lately that one of the most public-facing US bankers, Jamie Dimon, delivered us a future warning that could

Tech Letter

May 3, 2024 - Quote of the Day

Man is not free unless government is limited.” – Said Former US President Ronald Reagan  

Jacque's Post

May 3, 2024

  SUMMARY OF JOHN’S MAY 1, 2024, WEBINAR) May 3, 2024   Hello everyone, TITLE:  Digestion Time TRADE ALERT PERFORMANCE: 2024 YTD: +14.61% Since inception:  +690.24% Average annualized return: +51.77% for 16 years   PORTFOLIO REVIEW: Risk On: NVDA 5/$710-$720 call spread TLT 5/$82-$85 call spread META 5/$360-$370 call spread GLD 5/$200-$205 call spread Risk

Diary, Newsletter, Summary

May 3, 2024

Global Market Comments May 3, 2024 Fiat Lux   Featured Trade: (MAY 1 BIWEEKLY STRATEGY WEBINAR Q&A), (TSLA), (TLT), (GOLD), (GLD), (WPM), (NVDA), (OXY), (XOM)

Diary, Newsletter

May 1 Biweekly Strategy Webinar Q&A

Below please find subscribers’ Q&A for the May 1 Mad Hedge Fund Trader Global Strategy Webinar, broadcast from Silicon Valley. Q: I see the Bank of Japan bought $35 billion in the foreign exchange on the market. What's going on? A: First of all, they didn’t buy dollars, they sold dollars and bought yen. Well,

Biotech Letter

May 2, 2024

Mad Hedge Biotech and Healthcare Letter May 2, 2024 Fiat Lux   Featured Trade: (BUT WEIGHT, THERE’S MORE) (LLY), (NVO)

Biotech Letter

But Weight, There's More

You know that feeling when you find a crumpled $20 bill in an old jacket? That’s a little like what Eli Lilly must be feeling with tirzepatide, only replace that $20 with a cool $34 billion forecast by 2029. Yeah, it’s been that kind of party over at Lilly. Tirzepatide, the magic ingredient in both

Diary, Newsletter, Summary

May 2, 2024

Global Market Comments May 2, 2024 Fiat Lux   Featured Trade: (THE UNITED STATES OF DEBT) (TLT)

Tech Letter

May 1, 2024

Mad Hedge Technology Letter May 1, 2024 Fiat Lux   Featured Trade: (THE BIG RETAILER DIVING INTO FINTECH) (WMT), (PYPL)

Tech Letter

The Big Retailer Diving Into Fintech

The takeaway I get from Walmart’s (WMT) push into fintech is that fintech is becoming mighty crowded in the short-term and this trend most likely won’t change anytime soon. Walmart has been one of the big companies trying to beef up online commerce so it’s no surprise that wants to marry up this initiative with

Page 144 of 227«‹142143144145146›»

tastytrade, Inc. (“tastytrade”) has entered into a Marketing Agreement with Mad Hedge Fund Trader (“Marketing Agent”) whereby tastytrade pays compensation to Marketing Agent to recommend tastytrade’s brokerage services. The existence of this Marketing Agreement should not be deemed as an endorsement or recommendation of Marketing Agent by tastytrade and/or any of its affiliated companies. Neither tastytrade nor any of its affiliated companies is responsible for the privacy practices of Marketing Agent or this website. tastytrade does not warrant the accuracy or content of the products or services offered by Marketing Agent or this website. Marketing Agent is independent and is not an affiliate of tastytrade. 

Legal Disclaimer

There is a very high degree of risk involved in trading. Past results are not indicative of future returns. MadHedgeFundTrader.com and all individuals affiliated with this site assume no responsibilities for your trading and investment results. The indicators, strategies, columns, articles and all other features are for educational purposes only and should not be construed as investment advice. Information for futures trading observations are obtained from sources believed to be reliable, but we do not warrant its completeness or accuracy, or warrant any results from the use of the information. Your use of the trading observations is entirely at your own risk and it is your sole responsibility to evaluate the accuracy, completeness and usefulness of the information. You must assess the risk of any trade with your broker and make your own independent decisions regarding any securities mentioned herein. Affiliates of MadHedgeFundTrader.com may have a position or effect transactions in the securities described herein (or options thereon) and/or otherwise employ trading strategies that may be consistent or inconsistent with the provided strategies.

Copyright © 2025. Mad Hedge Fund Trader. All Rights Reserved. support@madhedgefundtrader.com
  • Privacy Policy
  • Disclaimer
  • FAQ
Scroll to top